Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:2313-2322
Published online before print April 20, 2009, doi: 10.1161/CIRCULATIONAHA.108.782458
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
119/17/2313    most recent
CIRCULATIONAHA.108.782458v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, Y.
Right arrow Articles by Yuan, J. X.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, Y.
Right arrow Articles by Yuan, J. X.-J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Ion channels/membrane transport
Right arrow Pulmonary biology and circulation
Right arrow Smooth muscle proliferation and differentiation
Right arrow Pulmonary circulation and disease
Right arrowRelated Articles

(Circulation. 2009;119:2313-2322.)
© 2009 American Heart Association, Inc.


Hypertension

A Functional Single-Nucleotide Polymorphism in the TRPC6 Gene Promoter Associated With Idiopathic Pulmonary Arterial Hypertension

Ying Yu, MD, PhD; Steve H. Keller, PhD; Carmelle V. Remillard, PhD; Olga Safrina, PhD; Ann Nicholson, MS; Shenyuan L. Zhang, PhD; Weihua Jiang, PhD; Nivruthi Vangala, BA; Judd W. Landsberg, MD; Jian-Ying Wang, MD, PhD; Patricia A. Thistlethwaite, MD, PhD; Richard N. Channick, MD; Ivan M. Robbins, MD; James E. Loyd, MD; Hossein A. Ghofrani, MD; Friedrich Grimminger, MD, PhD; Ralph T. Schermuly, PhD; Michael D. Cahalan, PhD; Lewis J. Rubin, MD; Jason X.-J. Yuan, MD, PhD

From the Departments of Medicine (Y.Y., S.H.K., A.N., N.V., C.V.R., J.W.L., RNC., L.J.R., J.X.-J.Y.) and Surgery (P.A.T.), University of California, San Diego, La Jolla; Department of Physiology and Biophysics (Y.Y., O.S., S.L.Z., W.J., M.D.C.), University of California, Irvine; Department of Surgery (J.-Y.W.), University of Maryland, Baltimore; Department of Medicine (I.M.R., J.E.L.), Vanderbilt University School of Medicine, Nashville, Tenn; and the Department of Internal Medicine II/V (H.A.G., F.G., R.T.S.), Justus Liebig University Giessen, Giessen, Germany. Dr Yu is currently at Alcon Laboratories, Fort Worth, Tex.

Reprint requests to Jason X.-J. Yuan, MD, PhD, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Diego, 9500 Gilman Dr, MC 0725, La Jolla, CA 92093-0725 (e-mail xiyuan{at}ucsd.edu); or Ying Yu, MD, PhD, Alcon Laboratories Inc, 6201 S Freeway, Ft Worth, TX 76134 (e-mail Ying.Yu@AlconLabs.com).

Received March 25, 2008; accepted February 2, 2009.

Background— Excessive proliferation of pulmonary artery smooth muscle cells (PASMCs) plays an important role in the development of idiopathic pulmonary arterial hypertension (IPAH), whereas a rise in cytosolic Ca2+ concentration triggers PASMC contraction and stimulates PASMC proliferation. Recently, we demonstrated that upregulation of the TRPC6 channel contributes to proliferation of PASMCs isolated from IPAH patients. This study sought to identify single-nucleotide polymorphisms (SNPs) in the TRPC6 gene promoter that are associated with IPAH and have functional significance in regulating TRPC6 activity in PASMCs.

Methods and Results— Genomic DNA was isolated from blood samples of 237 normal subjects and 268 IPAH patients. Three biallelic SNPs, –361 (A/T), –254(C/G), and –218 (C/T), were identified in the 2000-bp sequence upstream of the transcriptional start site of TRPC6. Although the allele frequencies of the –361 and –218 SNPs were not different between the groups, the allele frequency of the –254(C->G) SNP in IPAH patients (12%) was significantly higher than in normal subjects (6%; P<0.01). Genotype data showed that the percentage of –254G/G homozygotes in IPAH patients was 2.85 times that of normal subjects. Moreover, the –254(C->G) SNP creates a binding sequence for nuclear factor-{kappa}B. Functional analyses revealed that the –254(C->G) SNP enhanced nuclear factor-{kappa}B-mediated promoter activity and stimulated TRPC6 expression in PASMCs. Inhibition of nuclear factor-{kappa}B activity attenuated TRPC6 expression and decreased agonist-activated Ca2+ influx in PASMCs of IPAH patients harboring the –254G allele.

Conclusions— These results suggest that the –254(C->G) SNP may predispose individuals to an increased risk of IPAH by linking abnormal TRPC6 transcription to nuclear factor-{kappa}B, an inflammatory transcription factor.


 

CLINICAL PERSPECTIVE


Related Articles:

Clinical Summaries
Circulation 2009 119: 2295-2296. [Extract] [Full Text]

Evidence for Inflammatory Signaling in Idiopathic Pulmonary Artery Hypertension: TRPC6 and Nuclear Factor-{kappa}B
Rizwan Hamid and John H. Newman
Circulation 2009 119: 2297-2298. [Extract] [Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
R. Hamid and J. H. Newman
Evidence for Inflammatory Signaling in Idiopathic Pulmonary Artery Hypertension: TRPC6 and Nuclear Factor-{kappa}B
Circulation, May 5, 2009; 119(17): 2297 - 2298.
[Full Text] [PDF]